In the current study, all hypertensive COVID-19 patients in 15 departments of the hospital during the local epidemic period were investigated to study the severity of SARS-CoV-2 infection in hypertensive COVID-19 patients with or without AT1R blocker treatment. Here, AGTR1 is linked to COVID-19.